Search Results - George Mells
- Showing 1 - 20 results of 29
- Go to Next Page
-
1
Reducing the Risks of Cardiovascular Disease in Liver Allograft Recipients by George Mells, James Neuberger
Published 2007Revisão -
2
-
3
-
4
Gene polymorphisms of cellular senescence marker p21 and disease progression in non-alcohol-related fatty liver disease by Aloysious Aravinthan, George Mells, Michael Allison, Julian Leathart, Anna Kotronen, Hannele Yki‐Järvinen, Ann K. Daly, Christopher P. Day, Quentin M. Anstee, Graeme Alexander
Published 2014Artigo -
5
-
6
The inter‐relationship of symptom severity and quality of life in 2055 patients with primary biliary cholangitis by Jessica Dyson, Nina Wilkinson, Laura Jopson, George Mells, Andrew Bathgate, M. Heneghan, James Neuberger, Gideon M. Hirschfield, SJ Ducker, Richard Sandford, Graeme Alexander, Deborah Stocken, Diana Jones
Published 2016Artigo -
7
Impact of primary biliary cirrhosis on perceived quality of life: The UK-PBC national study by George Mells, Greta Pells, Julia L. Newton, Andrew Bathgate, Andrew K. Burroughs, Michael A. Heneghan, James Neuberger, Darren B. Day, Samantha Ducker, Richard Sandford, Graeme Alexander, David Jones
Published 2013Artigo -
8
Sex and Age Are Determinants of the Clinical Phenotype of Primary Biliary Cirrhosis and Response to Ursodeoxycholic Acid by Marco Carbone, George Mells, Greta Pells, Muhammad F. Dawwas, Julia L. Newton, Michael A. Heneghan, James Neuberger, Darren B. Day, Samantha Ducker, Richard Sandford, Graeme Alexander, D. I. Jones
Published 2012Artigo -
9
Increased sensitivity of Treg cells from patients with PBC to low dose IL-12 drives their differentiation into IFN-γ secreting cells by Evaggelia Liaskou, Samita R. Patel, Gwilym J. Webb, Danai Bagkou Dimakou, Sarah Akiror, Mahesh Krishna, George Mells, Dave E. Jones, Simon Bowman, Francesca Barone, Benjamin A. Fisher, Gideon M. Hirschfield
Published 2018Artigo -
10
The impact of liver transplantation on the phenotype of primary biliary cirrhosis patients in the UK-PBC cohort by Greta Pells, George Mells, Marco Carbone, Julia L. Newton, Andrew Bathgate, Andrew K. Burroughs, Michael A. Heneghan, James Neuberger, Darren B. Day, Samantha Ducker, Richard Sandford, Graeme Alexander, D. I. Jones
Published 2013Artigo -
11
High mortality rates for SARS-CoV-2 infection in patients with pre-existing chronic liver disease and cirrhosis: Preliminary results from an international registry by Andrew M. Moon, Gwilym J. Webb, Costica Aloman, Matthew J. Armstrong, Tamsin Cargill, Renumathy Dhanasekaran, Joan Genescà, Upkar S. Gill, Theodore James, Patricia D. Jones, Aileen Marshall, George Mells, Ponni Perumalswami, Xiaolong Qi, Feng Su, Nneka N. Ufere, Eleanor Barnes, A. Sidney Barritt, Thomas Marjot
Published 2020Carta -
12
Bacterial and metabolic phenotypes associated with inadequate response to ursodeoxycholic acid treatment in primary biliary cholangitis by Laura Martinez‐Gili, Alexandros Pechlivanis, Julie A. K. McDonald, Sofina Begum, Jonathan Badrock, Jessica Dyson, Rebecca Jones, Gideon M. Hirschfield, Stephen Ryder, Richard Sandford, Simon Rushbrook, Douglas Thorburn, Simon D. Taylor‐Robinson, Mary M.E. Crossey, Julian R. Marchesi, George Mells, Elaine Holmes, David Jones
Published 2023Artigo -
13
Dense fine-mapping study identifies new susceptibility loci for primary biliary cirrhosis by Jimmy Z. Liu, Mohamed A. Almarri, Daniel J. Gaffney, George Mells, Luke Jostins, Heather J. Cordell, Samantha Ducker, Darren B. Day, Michael A. Heneghan, James Neuberger, Peter T. Donaldson, Andrew Bathgate, Andrew K. Burroughs, Mervyn H. Davies, D. I. Jones, Graeme Alexander, Jeffrey C. Barrett, Richard Sandford, Carl A. Anderson
Published 2012Artigo -
14
Genome-wide association study identifies 12 new susceptibility loci for primary biliary cirrhosis by George Mells, James Floyd, Katherine I. Morley, Heather J. Cordell, Christopher Franklin, So–Youn Shin, Michael A. Heneghan, James Neuberger, Peter T. Donaldson, Darren B. Day, Samantha Ducker, Agnes W Muriithi, Elizabeth F Wheater, Christopher J. Hammond, Muhammad F. Dawwas, D. I. Jones, Leena Peltonen, Graeme Alexander, Richard Sandford, Carl A. Anderson
Published 2011Revisão -
15
UK-Wide Multicenter Evaluation of Second-line Therapies in Primary Biliary Cholangitis by Nadir Abbas, Emma Culver, Douglas Thorburn, Neil Halliday, Hannah Crothers, Jessica Dyson, April Phaw, Richard Aspinall, Salim I. Khakoo, Yiannis Kallis, Belinda Smith, Imran Patanwala, Anne McCune, Chenchu Ramu Chimakurthi, Vinod S. Hegade, Michael Orrell, Rebecca Jones, George Mells, Colette Thain, Robert-Mitchell Thain, David Jones, Gideon M. Hirschfield, Palak Trivedi
Published 2022Artigo -
16
COBALT: A Confirmatory Trial of Obeticholic Acid in Primary Biliary Cholangitis With Placebo and External Controls by Kris V. Kowdley, Gideon M. Hirschfield, Charles Coombs, Elizabeth Smoot Malecha, Leona Bessonova, Jing Li, Nuvan Rathnayaka, George Mells, D. I. Jones, Palak Trivedi, Bettina E. Hansen, Rachel Smith, James Wason, Shaun Hiu, Dorcas Kareithi, Andrew L. Mason, Christopher L. Bowlus, Kate Muller, Marco Carbone, Marina Berenguer, Piotr Milkiewicz, Femi Adekunle, Alejandra Villamil
Published 2024Artigo -
17
The UK‐PBC risk scores: Derivation and validation of a scoring system for long‐term prediction of end‐stage liver disease in primary biliary cholangitis by Marco Carbone, Stephen J. Sharp, Steve Flack, Debasish Das, Kelly Spiess, Carolyn Adgey, Laura Griffiths, R.T. Lim, Paul Trembling, Kate D. Williamson, Nicholas J. Wareham, Mark Aldersley, Andrew Bathgate, Andrew K. Burroughs, Michael A. Heneghan, James Neuberger, Douglas Thorburn, Gideon M. Hirschfield, Heather J. Cordell, Graeme Alexander, D. I. Jones, Richard Sandford, George Mells
Published 2015Artigo -
18
Factors Associated With Outcomes of Patients With Primary Sclerosing Cholangitis and Development and Validation of a Risk Scoring System by Elizabeth C. Goode, Allan Clark, George Mells, Brijesh Srivastava, Kelly Spiess, William Gelson, Palak Trivedi, Kate D. Lynch, Edit Castren, Mette Vesterhus, Tom H. Karlsen, Sun‐Gou Ji, Carl A. Anderson, Douglas Thorburn, Mark Hudson, Michael A. Heneghan, Mark Aldersley, Andrew Bathgate, Richard Sandford, Graeme Alexander, Roger W. Chapman, Martine Walmsley, Gideon M. Hirschfield, Simon Rushbrook
Published 2018Artigo -
19
Primary biliary cholangitis drug evaluation and regulatory approval: Where do we go from here? by David Jones, Ulrich Beuers, Alan Bonder, Marco Carbone, Emma Culver, Jessica Dyson, Robert G. Gish, Bettina E. Hansen, Gideon M. Hirschfield, Rebecca Jones, Kris V. Kowdley, Andreas E. Kremer, Keith D. Lindor, Marlyn J. Mayo, George Mells, James Neuberger, Martin Prince, Mark G. Swain, Atsushi Tanaka, Douglas Thorburn, Michael Trauner, Palak Trivedi, Martin Weltman, Andrew D. Yeoman, Cynthia Levy
Published 2024Artigo -
20
Outcomes following SARS-CoV-2 infection in patients with chronic liver disease: An international registry study by Thomas Marjot, Andrew M. Moon, Jonathan Cook, Sherief Abd‐Elsalam, Costica Aloman, Matthew J. Armstrong, Elisa Pose, Erica J. Brenner, Tamsin Cargill, M.-A Catana, Renumathy Dhanasekaran, Ahad Eshraghian, Ignacio García‐Juárez, Upkar S. Gill, Patricia D. Jones, James Kennedy, Aileen Marshall, Charmaine Matthews, George Mells, Carolyn Mercer, Ponni Perumalswami, Emma Avitabile, Xialong Qi, Feng Su, Nneka N. Ufere, Yu Jun Wong, Ming‐Hua Zheng, Eleanor Barnes, A. Sidney Barritt, Gwilym J. Webb
Published 2020Artigo
Search Tools:
Related Subjects
Medicine
Internal medicine
Gastroenterology
Biology
Disease
Gene
Cohort
Primary biliary cirrhosis
Ursodeoxycholic acid
Genetics
Genotype
Primary sclerosing cholangitis
Single-nucleotide polymorphism
Immunology
Biochemistry
Cirrhosis
Genome-wide association study
Transplantation
Liver disease
Liver transplantation
Pathology
Receptor
Agonist
Allele
Chronic liver disease
Environmental health
Genetic association
Immunosuppression
In vitro
Locus (genetics)